Diagnostic Testing & Technology Report
July 2009
With New CLIA Lab, Perlegen Plans Fall Launch of Breast Cancer Test
Perlegen Sciences (Mountain View, Calif.), a 2001 spin-off of genetic analysis giant Affymetrix (Santa Clara, Calif.), is gearing up for the fall launch of its first product: a novel genetic test to help determine a patient’s risk of developing breast cancer. On June 4, the company opened a clinical laboratory at its Mountain View headquarters after a successful inspection for CLIA licensure by the California Department of Public Health’s Laboratory Field Services.
Login | Subscribe
July 2009 - Table of Contents
Diagnostic Testing & Technology Report is part of...
Focus Areas |
Product Group |
 G2 Reports Medical Lab Management |
Newsletters |